Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more
Arvee Laboratories (India) Limited (ARVEE) - Total Liabilities
Latest total liabilities as of September 2025: ₹91.40 Million INR
Based on the latest financial reports, Arvee Laboratories (India) Limited (ARVEE) has total liabilities worth ₹91.40 Million INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Arvee Laboratories (India) Limited - Total Liabilities Trend (2013–2025)
This chart illustrates how Arvee Laboratories (India) Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Arvee Laboratories (India) Limited Competitors by Total Liabilities
The table below lists competitors of Arvee Laboratories (India) Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Less Mess Storage Inc.
V:LMS
|
Canada | CA$405.15K |
|
YSX Tech. Co., Ltd Class A Ordinary Shares
NASDAQ:YSXT
|
USA | $16.96 Million |
|
Pegasus Heights Bhd
KLSE:4464
|
Malaysia | RM7.41 Million |
|
Multi Makmur Lemindo
JK:PIPA
|
Indonesia | Rp23.50 Billion |
|
MetaLabs Co Ltd
KO:090370
|
Korea | ₩127.02 Billion |
|
Bridgford Foods Corporation
NASDAQ:BRID
|
USA | $9.36 Million |
|
Urban One
NASDAQ:UONE
|
USA | $642.06 Million |
|
Soligenix Inc.
NASDAQ:SNGX
|
USA | $3.70 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Arvee Laboratories (India) Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Arvee Laboratories (India) Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Arvee Laboratories (India) Limited (2013–2025)
The table below shows the annual total liabilities of Arvee Laboratories (India) Limited from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹68.97 Million | -24.08% |
| 2024-03-31 | ₹90.85 Million | -14.48% |
| 2023-03-31 | ₹106.23 Million | -27.94% |
| 2022-03-31 | ₹147.43 Million | -24.81% |
| 2021-03-31 | ₹196.08 Million | +31.28% |
| 2020-03-31 | ₹149.36 Million | -27.80% |
| 2019-03-31 | ₹206.88 Million | -30.85% |
| 2018-03-31 | ₹299.18 Million | -4.96% |
| 2017-03-31 | ₹314.81 Million | -3.34% |
| 2016-03-31 | ₹325.69 Million | +32.32% |
| 2015-03-31 | ₹246.14 Million | +71.40% |
| 2014-03-31 | ₹143.60 Million | +62.92% |
| 2013-03-31 | ₹88.14 Million | -- |